Palvella Therapeutics Stock Alpha and Beta Analysis
| PVLA Stock | 101.70 2.97 2.84% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Palvella Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Palvella Therapeutics over a specified time horizon. Remember, high Palvella Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Palvella Therapeutics' market risk premium analysis include:
Beta 1.42 | Alpha 0.82 | Risk 4.74 | Sharpe Ratio 0.16 | Expected Return 0.75 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Palvella Therapeutics Backtesting, Palvella Therapeutics Valuation, Palvella Therapeutics Correlation, Palvella Therapeutics Hype Analysis, Palvella Therapeutics Volatility, Palvella Therapeutics History and analyze Palvella Therapeutics Performance. Palvella Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Palvella Therapeutics market risk premium is the additional return an investor will receive from holding Palvella Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Palvella Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Palvella Therapeutics' performance over market.| α | 0.82 | β | 1.42 |
Palvella Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Palvella Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Palvella Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Palvella Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Palvella Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Palvella Therapeutics shares will generate the highest return on investment. By understating and applying Palvella Therapeutics stock market price indicators, traders can identify Palvella Therapeutics position entry and exit signals to maximize returns.
Palvella Therapeutics Return and Market Media
The median price of Palvella Therapeutics for the period between Sat, Oct 4, 2025 and Fri, Jan 2, 2026 is 81.54 with a coefficient of variation of 15.41. The daily time series for the period is distributed with a sample standard deviation of 13.04, arithmetic mean of 84.61, and mean deviation of 11.74. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Palvella Therapeutics GAAP EPS of -1.03 misses by 0.19 | 11/11/2025 |
2 | Palvella Therapeutics Stock Price Down 7.9 percent Should You Sell | 12/01/2025 |
3 | Palvella Therapeutics Sees Strong Trading Volume Heres Why | 12/05/2025 |
4 | Palvella Therapeutics Announces Positive Topline Results from Phase 2 TOIVA Clinical Trial of QTORIN 3.9 percent Rapamycin Anhydrous Gel for the Treatment of Cu... | 12/15/2025 |
5 | Palvella Therapeutics Granted FDA Fast Track Designation for QTORIN 3.9 percent Rapamycin Anhydrous Gel for the Treatment of Angiokeratomas | 12/16/2025 |
6 | Assessing Palvella Therapeutics After Its 666.8 percent Surge and Late Stage Pipeline Progress | 12/19/2025 |
7 | Palvella Therapeutics Sets New 52-Week High - Still a Buy - MarketBeat | 12/22/2025 |
About Palvella Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Palvella or other stocks. Alpha measures the amount that position in Palvella Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2025 | 2026 (projected) | Interest Debt Per Share | 18.45 | 1.94 | 2.23 | 2.12 | Revenue Per Share | 38.94 | 27.84 | 32.02 | 40.27 |
Palvella Therapeutics Investors Sentiment
The influence of Palvella Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Palvella. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Palvella Therapeutics' public news can be used to forecast risks associated with an investment in Palvella. The trend in average sentiment can be used to explain how an investor holding Palvella can time the market purely based on public headlines and social activities around Palvella Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Palvella Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Palvella Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Palvella Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Palvella Therapeutics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Palvella Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Palvella Therapeutics' short interest history, or implied volatility extrapolated from Palvella Therapeutics options trading.
Build Portfolio with Palvella Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Palvella Therapeutics Backtesting, Palvella Therapeutics Valuation, Palvella Therapeutics Correlation, Palvella Therapeutics Hype Analysis, Palvella Therapeutics Volatility, Palvella Therapeutics History and analyze Palvella Therapeutics Performance. For information on how to trade Palvella Stock refer to our How to Trade Palvella Stock guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Palvella Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.